NeuroNova AB
Stockholm, SE· latest recorded location
NeuroNova AB is named on 7 US grants and 6 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 7
- Published applications
- 6
- Inventors
- 30
- Granted in 2026 so far
- 0
- Most recent grant
- 27 Nov 2012
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 1 | 2 |
| 2004 | 0 | 0 |
| 2005 | 1 | 1 |
| 2006 | 0 | 0 |
| 2007 | 1 | 0 |
| 2008 | 1 | 1 |
| 2009 | 0 | 0 |
| 2010 | 1 | 0 |
| 2011 | 1 | 1 |
| 2012 | 1 | 1 |
By publication year.
Technology areas
Share of 13 documents
Recent patents
- Modulation of neural stem cells and neural progenitor cells27 Nov 2012US 8,318,704 B2
- Treatment of Parkinson's disease with PDGF19 Jul 2011US 7,981,863 B2
- Modulation of neural stem cells and neural progenitor cells12 Oct 2010US 7,811,822 B2
- Ependymal neural stem cells and method for their isolation22 Jan 2008US 7,320,872 B2
- Method of isolating ependymal neural stem cells9 Oct 2007US 7,279,332 B2
- Treatment of Central Nervous System Disorders29 Mar 2012US 2012/0077741 A1
- Modulation of neural stem cells and neural progenitor cells4 Aug 2011US 2011/0189184 A1
- Modulation of neural stem cells and neural progenitor cells4 Sep 2008US 2008/0213276 A1
- Compounds and methods for increasing neurogenesis13 Jan 2005US 2005/0009742 A1
- Treatment of central nervous system disorders30 Oct 2003US 2003/0203844 A1
Most cited
By later US patents
- Compounds and methods for increasing neurogenesis67US 6,969,702 B22005
- Modulation of neural stem cells and neural progenitor cells3US 7,811,822 B22010
- Method of isolating ependymal neural stem cells1US 6,541,247 B12003
- Method of isolating ependymal neural stem cells1US 7,279,332 B22007
- Ependymal neural stem cells and method for their isolation1US 7,320,872 B22008